Obesity is characterized by accumulation of excess body fat, while lipodystrophy is characterized by loss or absence of body fat. Despite their opposite phenotypes, these two conditions both cause ectopic lipid storage in non-adipose tissues, leading to lipotoxicity, which has health-threatening consequences. The exact mechanisms underlying ectopic lipid storage remain elusive. Here we report the analysis of a Drosophila model of the most severe form of human lipodystrophy, Berardinelli-Seip Congenital Lipodystrophy 2, which is caused by mutations in the BSCL2/Seipin gene. In addition to reduced lipid storage in the fat body, dSeipin mutant flies accumulate ectopic lipid droplets in the salivary gland, a non-adipose tissue. This phenotype was suppressed by expressing dSeipin specifically within the salivary gland. dSeipin mutants display synergistic genetic interactions with lipogenic genes in the formation of ectopic lipid droplets. Our data suggest that dSeipin may participate in phosphatidic acid metabolism and subsequently down-regulate lipogenesis to prevent ectopic lipid droplet formation. In summary, we have demonstrated a tissue-autonomous role of dSeipin in ectopic lipid storage in lipodystrophy.
Introduction
Lipids are major membrane components as well as the main source of cellular energy. Cells have developed precise homeostatic mechanisms to tightly regulate lipid uptake, synthesis, storage, and usage [1, 2] . Abnormalities in lipid metabolism often lead to disease states: excess body fat can lead to obesity while loss or absence of body fat results in lipodystrophy [3] . In vertebrates, white adipose tissue is the main lipid storage organ; however, ectopic lipid storage in non-adipose tissues such as muscle, pancreas, and liver, is often observed in disease states such as obesity and lipodystrophy. Lipotoxicity as a result of ectopic lipid storage in these diseases is thought to be a major cause of severe pathological conditions including insulin resistance, pancreatic b-cell failure, and hepatic steatosis [4] [5] [6] .
Ectopic lipid storage could be due to cell-extrinsic effects or cellintrinsic effects. Extrinsically, overflow of excess lipids that can no longer be stored in adipose tissues leads to lipid droplet formation in non-adipose tissues [7, 8] . In one study, surgical implantation of normal adipose tissue back into lipoatrophic mice reversed ectopic lipid accumulation in the liver, suggesting a tissue-non-autonomous mechanism [9] . On the other hand, defects within nonadipose tissues have also been postulated to contribute to ectopic lipid storage intrinsically, suggesting a positive role of non-adipose tissue in lipid storage. For example, removal of the transcription factor PPAR-d specifically from cardiomyocytes results in decreased fatty acid oxidation and severe lipid storage in the heart [10] . Currently, the contribution of extrinsic and intrinsic mechanisms to ectopic lipid storage in non-adipose tissues in various diseases conditions remains to be determined.
Berardinelli-Seip Congenital Lipodystrophy (BSCL), the most severe form of lipodystrophy in humans, is caused by mutations in either BSCL1 or BSCL2. BSCL1 encodes acylglycerol phosphate acyltransferase 2 (AGPAT2), which is involved in triacylglycerol (TAG) biosynthesis, while BSCL2 encodes Seipin [11, 12] . Although BSCL1 and BSCL2 patients exhibit similar disease pathology, the causal link between Seipin and AGPAT2 is unclear. BSCL2 patients are born with nearly no adipose tissue and have ectopic lipid storage in muscle and liver, implying that human Seipin (hSeipin) may be required for adipocyte survival or differentiation [13, 14] .
Within cells, lipids are stored in specialized organelles called lipid droplets. The surface of the lipid droplet is a monolayer of polar lipids in which are embedded coat proteins that may be important for lipid homeostasis. The core of the lipid droplet contains neutral lipids, predominantly TAG and sterol esters [15] [16] [17] . Recent studies in both yeast and human cells suggested that Seipin may regulate the morphogenesis of lipid droplets. Yeast Seipin mutant cells contain irregular clustered lipid droplets and sometimes giant lipid droplets, while human BSCL2/Seipin mutant fibroblasts were found to contain numerous small lipid droplets [18, 19] . Nevertheless, the exact role of Seipin in human and yeast remains obscure. In addition, there is no plausible explanation for the cause of the ectopic lipid storage within non-adipose tissues in human Seipin patients. The lack of adipose and non-adipose tissues in yeast makes it impossible to uncover the mechanisms of ectopic lipid storage using yeast mutants. Therefore, it is important to utilize suitable model organisms that have both adipose and nonadipose tissues to study Seipin function and gain insights into the underlying mechanisms of ectopic lipid storage and lipid droplet formation.
As a multi-cellular model organism, Drosophila and its cell lines have been widely used to study conserved mechanisms of lipid metabolism [20] [21] [22] [23] [24] [25] . Here we report that Drosophila Seipin (dSeipin) mutants have reduced lipid storage in the fat body, an adipose tissue, while exhibiting ectopic lipid droplets in the salivary gland, a non-adipose tissue. We also found that dSeipin functions tissueautonomously in both tissues. Further genetic and lipidomic analyses revealed that in the salivary gland dSeipin genetically interacts with lipogenic genes likely at the level of phosphatidic acid (PA). Our studies uncover an unexpected tissue-autonomous mechanism in ectopic lipid storage and provide an attractive model system with which to dissect lipid metabolism in vivo.
Results

Drosophila Seipin mutants have reduced lipid storage in the fat body
A single Drosophila homolog of human Seipin, CG9904, was identified through Blast sequence comparisons and named as dSeipin ( Figure 1A and Figure S1 ). The middle portion of dSeipin (aa , including two potential transmembrane domains, shares 40% identity and 63% similarity to hSeipin. To study the function of dSeipin, we examined the expression profile of dSeipin mRNA using quantitative-RT-PCR (qRT-PCR). We found that dSeipin was widely expressed in many tissues with the highest expression in the fat body and moderate expression in the salivary gland, midgut and muscle ( Figure 1B) . We also examined the expression of dSeipin mRNA through in situ hybridization. At late embryonic stages, dSeipin mRNA is highly expressed in the hindgut. At larval stages, dSeipin mRNA is expressed in the fat body, anterior midgut and salivary gland ( Figure S1 ).
As an entry point to explore the function of dSeipin in vivo, we analyzed the subcellular localization of YFP-tagged dSeipin using the UAS-Gal4 system, where the target gene downstream of the UAS element is activated by the transcriptional activator Gal4. We confirmed that the YFP-tagged dSeipin protein is functional (data not shown). We then used a fat body-and salivary gland-specific Gal4 driver, ppl-Gal4 [26] , to express dSeipin-YFP in the fat body. dSeipin-YFP is colocalized with the ER marker PDI-GFP ( Figure  S1 ). In addition, dSeipin-YFP forms some puncta which might represent specific subdomains of the ER ( Figure S1 ). The similar subcellular localization patterns of dSeipin to its human and yeast counterparts [18] imply that dSeipin may perform conserved roles in the regulation of lipid droplet formation and lipid storage.
We next examined the role of dSeipin through mutant phenotypic analysis. We generated a deletion allele of dSeipin using an ends-out gene targeting approach. This allele lacks the whole genomic region of dSeipin and is a null allele as confirmed by RT-PCR ( Figure 1A and 1C) . dSeipin mutants are viable and fertile with no noticeable behavior defects. We used the neutral lipid stain Nile red to examine the morphology of the fat body, which is the adipose tissue of insects and also has liver-like activity due to its detoxification function. The larval fat bodies of dSeipin mutants have significantly reduced lipid storage, in contrast to wild-type fat bodies which have many large lipid droplets ( Figure 1D ). Similarly, in fat cells from young adults, dSeipin mutants have smaller lipid droplets compared to wild type. The small lipid droplet phenotype is more severe under starvation conditions ( Figure 1D ). This lipid droplet phenotype is similar to that of hSeipin mutant fibroblasts, which also contain small lipid droplets [18] . Further genetic rescue experiments supported the idea that the lipid storage phenotype is indeed due to the deletion of dSeipin (see below). These results indicate that dSeipin is required for proper lipid storage in the fat body. Except for the aberrant lipid droplets, the overall morphology of the fat body in the mutants appears normal.
Interestingly, the fat bodies from dSeipin mutants sink to the bottom of 2% sucrose solution while control fat bodies float on top ( Figure 1E ). This phenomenon is likely due to reduced lipid storage in the mutant fat bodies. We examined the total glyceride content and found that the glyceride level in dSeipin mutants is greatly reduced compared to control animals ( Figure 1F ). This phenotype can be rescued by ubiquitous expression of a UASdSeipin transgene ( Figure 1F ). dSeipin mutants are viable and fertile, but their average weight is lower than control flies ( Figure 1G ). The weight reduction phenotype can be fully rescued by expressing UAS-dSeipin ubiquitously with tub-Gal4 and partially rescued by expressing dSeipin in the fat body and salivary gland with ppl-Gal4 ( Figure 1G ).
dSeipin mutants likely have reduced lipogenesis in the fat body
What is the cause of reduced lipid storage in dSeipin mutants? Both increased lipolysis and reduced lipogenesis could potentially lead to the same reduced lipid storage phenotype. Results from the following experiments rule out the former possibility. We firstly investigated the levels of circulating lipids, which are elevated if lipolysis is increased. It has been previously reported that oenocytes (larval secretory cells) can be used to monitor the levels of circulating lipids [27] . Under fed conditions in wild type,
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oenocytes are weakly stained with the neutral lipid dye Oil Red O because of low circulating lipids and low levels of TAG biosynthesis in oenocytes. However, under starved conditions, lipolysis is stimulated in the fat body, resulting in high levels of circulating lipids and strong Oil Red O staining of oenocytes. Moreover, under fed conditions, increasing lipolysis by overexpression of BMM, the Drosophila homolog of mammalian adipocyte triglyceride lipase (ATGL) [28] , leads to strong Oil Red O staining in oenocytes [27] (Figure 2A ). We found that under fed conditions, there is no difference between Oil Red O staining of oenocytes in wild type and dSeipin mutants (Figure 2A) . Furthermore, in starved dSeipin mutants, although the Oil Red O staining signal is higher than in fed mutants, it is still much lower than that of wild type, reflecting the fact that less lipid is stored in the fat body of dSeipin mutants (Figure 2A ). To rule out the possibility that loss of dSeipin in oenocytes prevents them synthesizing TAG, we specifically expressed dSeipin in oenocytes with Cyp4g1-Gal4 in dSeipin mutants. We found that under starved conditions the Oil Red O staining signal is much lower than that of wild type ( Figure S3 ). These results indicate that circulating lipids in dSeipin mutants are not elevated under normal fed conditions. Moreover, we also measured the circulating glyceride levels and found it is significantly lower in dSeipin mutants than wild type, supporting the idea that lipolysis is not increased in dSeipin mutants ( Figure 2B ). LSD-2 is one of the two Drosophila lipid droplet surface PAT domain-containing proteins. Lsd-2 mutants may have slightly increased lipolysis [29] , but dSeipin;Lsd-2 double mutants exhibit a similar phenotype to dSeipin single mutants, suggesting that dSeipin likely does not genetically interact with Lsd-2 ( Figure 2C ). Taken together, these results indicate that the reduced lipid storage in dSeipin mutant fat bodies is unlikely to be due to increased lipolysis.
To test whether the reduced lipid storage phenotype is due to reduced lipogenesis in the mutants, we examined the genetic interaction of dSeipin with several known lipid storage regulators in Drosophila. Drosophila midway (mdy) encodes a diglyceride acyltransferase (DGAT), which is involved in the last step of TAG biosynthesis [30] . In a partial loss-of-function DGAT/mdy qx25 mutant alone, there is little effect on fat body lipid storage ( Figure 2C and 2D) . However, double mutants of dSeipin and DGAT have greatly reduced lipid storage compared to either single mutant ( Figure 2C and 2D) . Moreover, overexpression of DGAT or SCAP (SREBP cleavage activating protein), key positive regulators of lipogenesis [24] , suppresses the reduced lipid storage phenotype in dSeipin mutants ( Figure 2C and 2D ). Taken together, these results suggest that dSeipin mutants likely have reduced lipogenesis in the fat body.
Since stored lipid is an important energy supply during starvation stress, reduced lipid storage might be deadly during nutrient deprivation. We therefore tested whether dSeipin mutants are sensitive to starvation. Under starved conditions, more than half of wild type or controls survive for at least 48 hours, while 100% of dSeipin mutants die within 42 hours, indicating that dSeipin mutants are hypersensitive to starvation ( Figure 2E ). The reduced lipid storage and the increased sensitivity to starvation in dSeipin mutants raise the possibility that dSeipin mutants are always in a starved state under normal fed conditions. In wild-type flies, starvation can trigger autophagy in the fat body, so if dSeipin mutants are always in a starved state, the autophagy program should be active under normal culturing conditions. We used the conventional lysosomal dye lysotracker to detect autophagic cells; however, we found no difference in lysotracker staining between wild type and dSeipin mutants. Fat bodies from both genotypes were positively stained under starved conditions and negatively stained in normal conditions, suggesting that under normal feeding conditions dSeipin mutants are not limited in nutrition ( Figure S2 ).
Ectopic lipid droplets in dSeipin mutants
Besides reduced lipid storage in adipose tissue, another prominent phenotype of lipodystrophy is ectopic lipid storage in non-adipose tissues, such as muscle and liver. Therefore, we also performed lipid staining in other tissues from dSeipin mutants, including wing disc, gut, brain, muscle, epidermis and salivary gland. Among these tissues, gut and wing disc can store lipids under normal or fasting conditions [27] . Similar to the fat body, dSeipin mutants have reduced lipid storage in the wing disc ( Figure  S2 ). We did not find excess lipid storage in the brain, muscle and epidermis of dSeipin mutants ( Figure S2 ).
Interestingly, we found that the proventriculus had large lipid droplets in dSeipin mutants compared to small lipid droplets in wild type ( Figure 3A ). In the anterior midgut region, dSeipin mutants had much more stored lipid than wild type ( Figure 3A) . Moreover, we found that dSeipin mutants exhibit ectopic lipid droplets in the salivary gland, which normally lacks any visible lipid droplets and has never been found to serve as a lipid storage organ under any conditions. In wild-type salivary glands, Nile red staining is diffused in the cytoplasm, while in mutants many small Nile red-positive puncta were found ( Figure 3B ). The ectopic puncta in mutant salivary glands are bona fide lipid droplets because the lipid droplet surface marker LSD-1-mCherry forms typical ring-like structures surrounding them ( Figure 3C ). Together, our data show firstly that the Drosophila dSeipin mutation results in reduced lipogenesis and lipid storage in adipose tissue, and secondly that it causes ectopic lipid droplets in some nonadipose tissues.
dSeipin is required tissue-autonomously for ectopic lipid droplet formation in salivary gland
Since the ectopic lipid droplet phenotype has not been reported before in Drosophila, we decided to take a genetic approach to tackle the underlying mechanisms using the salivary gland and the gut as models. First, we asked whether the ectopic lipid storage in dSeipin mutants is caused by intrinsic tissue-autonomous mechanisms or extrinsic tissue-non-autonomous mechanisms.
To test in which tissue dSeipin function is required, we used the UAS-Gal4 system to express wild-type dSeipin in a tissue-specific manner in an otherwise dSeipin mutant background. Tissue-specific expression of dSeipin was also verified by qRT-PCR ( Figure S3 ). UAS-dSeipin driven by ppl-Gal4 (which is highly active in salivary gland and moderately active in fat body) rescued both lipid storage defects in the fat body and ectopic lipid storage in the salivary gland ( Figure 4A , 4C and Table S1 ). dSeipin expression driven by the fat body-specific Gal4, lsp2-Gal4 [31] , rescued the defects in the fat body but not in the salivary gland or in the gut ( Figure 4A , 4C and Figure S3 ). In contrast, dSeipin expression driven by a salivary gland-specific Gal4, sgs3-Gal4 (which is expressed at late L3 stage) [32] , fully rescued the ectopic lipid droplet phenotype in the salivary gland but not the lipid storage defects in the fat body or the ectopic lipid storage in the gut ( Figure 4A , 4C and Figure S3 ). We were unable to obtain a suitable proventriculus-or anterior midgut-specific Gal4 line for tissue-specific rescue. Nevertheless, these results indicate that the ectopic lipid droplets in the salivary gland and the midgut and the lipid storage defects in the fat body of dSeipin mutants are likely due to tissue-autonomous requirements of dSeipin. Furthermore, it implies that reduced lipogenesis in the fat body of dSeipin mutants did not lead to ectopic lipid storage in the salivary gland.
We further confirmed the tissue-autonomous requirements of dSeipin using a tissue-specific RNAi approach. The tissue-specific knockdowns of dSeipin were also confirmed by qRT-PCR ( Figure  S3 ). UAS-dSeipin RNAi driven by ppl-Gal4 caused ectopic lipid storage in the salivary gland with mild lipid storage defects in the fat body, supporting the tissue-autonomous role of dSeipin ( Figure 4B and 4C) . However, sgs3-Gal4-driven dSeipin RNAi did not result in ectopic lipid storage in the salivary gland. We reasoned that sgs3-Gal4 may act too late in the L3 larval stage to generate the RNAi effect. Indeed, UAS-dSeipin RNAi driven by either 48Y-Gal4 or elav-Gal4, which is expressed in salivary gland much earlier than sgs3-Gal4 (Table S1 ), caused ectopic lipid droplet formation in the salivary gland ( Figure 4B and 4C) . Taking the data together, we concluded that dSeipin is required tissueautonomously for preventing ectopic lipid droplet formation in salivary gland.
dSeipin likely negatively affects lipid storage in salivary gland
The tissue-autonomous role of dSeipin prompted us to further explore the intrinsic mechanism of ectopic lipid droplet formation in dSeipin mutant salivary glands. Both increased lipogenesis and reduced lipolysis could theoretically result in lipid droplet formation. Which pathway is altered in dSeipin mutants and what is the function of dSeipin in that particular pathway?
bmm is a key positive regulator of lipolysis [28] . bmm loss-offunction mutants have reduced lipolysis, and display progressive obesity with increased synthesis of TAG, while overexpression of bmm results in a lean phenotype [21] . We found that bmm mutants have no ectopic lipid storage, suggesting that the ectopic lipid storage in salivary glands is not due to decreased lipolysis ( Figure 5A and 5B). In addition, we found no ectopic lipid In dSeipin mutants, the droplets in the proventriculus (arrow) are larger than wild type and in the anterior midgut (arrowhead) there are more patches of Oil Red O-positive staining. The boxed regions of the proventriculus and the midgut are enlarged in the adjacent panels. Scale bar: 100 mm. (B) Nile red staining in salivary glands. In wild-type salivary glands, essentially no punctate Nile red staining was found. In dSeipin mutants, many Nile red-positive puncta are present, indicating ectopic lipid storage. Scale bar: 100 mm. (C) Ectopic lipid puncta marked by Bodipy 493/503 (green) in dSeipin mutant salivary glands are confirmed as lipid droplets by co-labeling with the lipid droplet surface marker LSD-1-mCherry (red). Nuclei were stained with DAPI (blue). Scale bar: 50 mm. The lower panels show enlarged views from a dSeipin mutant. Expression of LSD-1-mCherry in a wild-type background was used as a control. doi:10.1371/journal.pgen.1001364.g003 droplets in the salivary gland of Lsd-2 mutants ( Figure 5C ), which also have a lean phenotype. Overexpression of Lsd-2 with ppl-Gal4 did not result in the ectopic lipid droplet phenotype either (data not shown). We next examined the lipogenic pathway. There are many enzymatic steps involved in the biosynthesis of TAG from fatty acids ( Figure 5I ) [33] . Firstly, fatty acids are converted to fatty acyl-CoA by acetyl-CoA synthetase (ACS). Fatty acyl-CoA has two different fates, either fatty acid oxidation to provide energy, or conversion to lysophosphatidic acid (LPA) by glycerol-3-phosphate acyltransferase (GPAT). Thus GPAT regulates the first committed step in lipogenesis and is likely a rate-limiting factor in lipogenesis [33, 34] . Acylglycerol phosphate acyltransferase (AGPAT) then adds another acyl chain to LPA to generate PA. PA can be converted to cytidine diphosphate diacylglycerol (CDP-DAG) by CDP diglyceride synthetase (CDS) or alternatively to DAG by Lipin, a PA phosphatase. CDP-DAG is the precursor of phosphatidylinositol (PI) and phosphatidylglycerol (PG). The last step in TAG biosynthesis, conversion of DAG to TAG, is catalyzed by DGAT. DAG can also be metabolized to phosphatidylcholine (PC) by choline phosphotransferase (CPT) Figure 4 . dSeipin functions tissue-autonomously in both salivary gland and fat body. (A) Tissue-specific rescue reveals tissue-autonomous function of dSeipin. Red: Nile red staining; blue: DAPI staining. The genotypes are indicated. ppl-Gal4 drives expression in both fat body and salivary gland. lsp2-Gal4 drives expression only in fat body, while sgs3-Gal4 drives expression only in salivary gland. lsp2.dSeipin is short for lsp2-Gal4.UAS-dSeipin, where dSeipin is overexpressed using the lsp-2-Gal4 driver. Note that dSeipin;lsp2.dSeipin animals have ectopic lipid storage in the salivary gland but exhibit normal lipid storage in the fat body and dSeipin;sgs3.dSeipin animals have lipid storage defects in the fat body but no lipid storage in the salivary gland. or to phosphatidylethanolamine (PE) by ethanolamine phosphotransferase (EPT). All these enzymes are conserved in Drosophila (Table S2 and data not shown). We verified by qRT-PCR that all the corresponding genes are expressed in salivary gland ( Figure  S4 ). Since GPAT is the rate-limiting enzyme, we reasoned that overexpressing GPAT could lead to increased lipogenesis. Indeed, we found that overexpression of GPAT1 (CG5508) using either 48Y-Gal4 or ppl-Gal4 in wild-type flies caused an ectopic lipid droplet phenotype, indicating that increased lipogenesis can lead to ectopic lipid storage ( Figure 5D , 5E and data not shown).
To examine whether dSeipin is involved in the lipogenesis pathway, we next analyzed the genetic interaction of dSeipin with GPAT1 and DGAT, two key genes in the lipogenic pathway. Overexpression of GPAT1 enhances the ectopic lipid storage phenotype of dSeipin mutants, consistent with the hypothesis that dSeipin mutants may have increased lipogenesis in non-adipose tissues ( Figure 5D , 5E, 5F and 5J). Furthermore, although overexpression of DGAT using either 48Y-Gal4 or ppl-Gal4 in wild type causes only mild lipid storage in salivary glands, overexpression of DGAT in a dSeipin mutant background results in a massive lipid storage phenotype in the salivary glands ( Figure 5D , 5G, 5H, 5J and data not shown). Under these conditions, the salivary gland appears more like a lipid storage organ. We also verified the genetic interactions between dSeipin and DGAT with Bodipy, another lipid dye ( Figure S4 ). Such strong synergistic genetic interactions in the metabolic pathway imply that in dSeipin mutants, DAG levels are likely increased in the salivary gland. Together, these results indicate that dSeipin probably negatively affects lipid storage in salivary gland.
dSeipin may participate in the metabolism of PA in the lipogenic pathway
We next investigated at which point dSeipin acts in the lipogenesis pathway ( Figure 5I ). We examined mutants of dSeipin that also had loss-of-function mutations of the main lipogenic genes including GPAT, AGPAT, Lipin, and DGAT. We found that the ectopic lipid storage phenotype in dSeipin mutants was fully suppressed by a DGAT mutation or by RNAi of either DGAT or Lipin using either 48Y-Gal4 or ppl-Gal4 ( Figure 6A , 6B, 6C, 6D, 6M and data not shown). These results indicate that dSeipin may act upstream of Lipin and DGAT. In contrast, a partial loss-of-function mutant of GPAT1 and RNAi of either AGPAT1 or AGPAT2, two AGPAT homologs, could not suppress the dSeipin phenotype ( Figure 6E , 6F, 6G, 6M and data not shown). Simultaneous RNAi of AGPAT1 and AGPAT2 also failed to suppress the dSeipin phenotype (data not shown). Due to the gene redundancy of GPAT and AGPAT, these results can't pinpoint the specific interaction between dSeipin and GPAT1 or AGPAT. It is possible that dSeipin may not interact with GPAT1 and AGPAT, or alternatively, dSeipin may act downstream of GPAT1 and AGPAT. Since the connection point between AGPAT and Lipin is PA ( Figure 5I ), it is possible that dSeipin may affect the metabolism of PA so that dSeipin mutants have altered levels of PA, which subsequently leads to increased DAG and lipid storage.
To test our hypothesis genetically, we examined the salivary glands of two other mutants. Cct1 is the rate limiting enzyme in PC biosynthesis, and loss of function of Cct1 may lead to increased DAG ( Figure 5I ). Cct1 RNAi was found to produce large lipid droplets in the S2 cell line [35] and Cct1 mutants contain large lipid droplets in the fat body (data not shown). However, the salivary glands of Cct1 16919 mutants do not show ectopic lipid storage, suggesting that the Cct1 16919 mutation alone is insufficient to cause ectopic lipid droplets ( Figure 6H and 6M) . CdsA is the sole Drosophila homolog of human CDS and a partial loss-of-function CdsA 1 mutant has increased levels of a single species of PA (PA 16:0/18:2, also called PA 34:2) ( Figure 5I ) [36] . In contrast to Cct1 16919 mutants, we found that Drosophila CdsA 1 mutants exhibit a similar ectopic lipid droplet phenotype to that of dSeipin mutants ( Figure 6I and 6M) . Therefore, we conclude that dSeipin may participate in PA metabolism.
We further checked the relationship between dSeipin and CdsA through double mutant analysis. CdsA 1 ;dSeipin double mutants exhibit a strong synergistic phenotype compared to either single mutant ( Figure 6J and 6M and Figure S4 ), indicating that dSeipin may function in parallel with CdsA. However, since CdsA 1 is a weak loss-of-function mutant, it is still possible that dSeipin functions in the same pathway as CdsA. In addition, overexpressing CdsA fully suppressed the ectopic lipid storage phenotype of dSeipin mutants ( Figure 6K, 6L and 6M) . Moreover, in Drosophila S2 cells, dSeipin also synergizes with CdsA in the formation of large lipid droplets ( Figure S4 ). Consistent with the dSeipin RNAi result, UAS-CdsA RNAi driven by 48Y-Gal4 or elav-Gal4, but not sgs3-Gal4, resulted in ectopic lipid storage in the salivary gland, reflecting a tissueautonomous role of CdsA and a tissue-autonomous mechanism of ectopic lipid droplet formation (data not shown). Taken together, these results suggest that dSeipin may be involved in the metabolism of PA and alteration of PA levels in dSeipin mutants may contribute to lipid droplets in salivary glands. 
PA and DAG levels are increased in dSeipin mutants
To directly analyze whether PA levels are indeed increased in dSeipin mutants, we performed a lipidomic analysis of dSeipin mutants and wild type. We found that in dSeipin mutant larvae the levels of total PA and most PA species are increased (including PA32:2, PA34:3, PA36:3, PA36:1) ( Figure 7A ). To further confirm the genetic interaction results, we also compared PA levels in the salivary glands of CdsA 1 and CdsA
1
;dSeipin double mutants and found that there was more PA in CdsA 1 ;dSeipin double mutants than CdsA 1 single mutants ( Figure 7B) . These results clearly demonstrate a role for dSeipin in the metabolism of PA.
In addition, the levels of total DAG and several DAG species, including 14:0/18:2, 16:1/18:2, 18: 0/18:2, 18:1/18:2 and 18:2/ 18:2, are all significantly increased in mutant salivary glands ( Figure 7C ). These results are consistent with the strong genetic interaction between dSeipin and DGAT ( Figure 5G , 5H and 5J). We also compared salivary gland TAG levels in different mutant backgrounds. In dSeipin mutants, the level of TAG is greatly reduced in the fat body, while the levels of several TAG species, including 46:3(18:2), 48:4(18:2), 50:4(18:2), 54:4(18:2), 54:5(18:2) are significantly increased in mutant salivary glands ( Figure 7D ). These results are consistent with the results obtained by Nile red staining (Figure 1) . Similarly, we found that the TAG levels in dSeipin may have distinct functions in fat body and salivary gland
The above results indicate that dSeipin mutants have reduced lipid storage in the fat body but increased formation of lipid droplets in the salivary gland. Since dSeipin functions tissue autonomously, how could its absence cause opposite phenotypes in these two tissues? It is possible that there are distinct functions of dSeipin in different tissues. Alternatively, dSeipin may have the same function, but different tissues might respond differently to the same alteration of lipid contents. We reasoned that if dSeipin has distinct functions in different tissues, it might have some structural differences to yeast Seipin, because yeast is a unicellular organism. We noticed that both dSeipin and hSeipin have an extended Cterminal region compared to yeast Seipin ( Figure 8A ). Does the structure difference between dSeipin and yeast Seipin reflect the different functional requirement in various tissues in flies? To test this, we made a transgene with a C-terminal truncation of dSeipin and examined its rescuing activity in the fat body and the salivary gland of dSeipin mutants. This transgene, when driven by ppl-Gal4, fully rescued the reduced lipid storage phenotype in the fat body, but not the ectopic lipid droplet phenotype in the salivary gland ( Figure 8B and 8C). Although this result does not rule out the possibility that dSeipin functions similarly in different tissues, which respond differently to altered lipid levels, it more strongly suggests that dSeipin may have distinct functions in fat body and salivary gland. Moreover, it echoes previous conclusions that dSeipin functions tissue-autonomously.
Seipin function is evolutionarily conserved
To test whether the function of Seipin is evolutionarily conserved, we expressed hSeipin in dSeipin mutants and examined its rescue effect. We found that hSeipin can functionally replace dSeipin in the fat body and the salivary gland. Lipid storage in the fat body is restored and ectopic lipid storage in the salivary gland is reversed in dSeipin mutants with ppl-Gal4-driven UAS-hSeipin ( Figure 8B and 8C ). N88S and S90L, two point mutations of hSeipin, were previously found to be associated with Silver syndrome, a dominant motor neuron degenerative disease [37] . The S90L hSeipin mutation also rescued the fat body and salivary gland phenotypes of dSeipin mutants, supporting the previous finding that S90L is likely a gain-of-function mutation (data not shown) [37] . These results indicate that the function of Seipin is conserved between fly and human.
Discussion
BSCL2 is a severe form of lipodystrophy which affects adipocyte development and results in ectopic lipid storage in non-adipose tissues. The exact function of BSCL2/Seipin and the causes of ectopic lipid storage are not known. Here we report analyses of the Drosophila dSeipin mutant. dSeipin mutants have reduced lipid storage in the fat body, which is the Drosophila adipose tissue, and ectopic lipid droplets in the salivary gland, a non-adipose tissue. It is worth noting that to the best of our knowledge the ectopic lipid droplet phenotype has not been reported previously in any invertebrate model organism.
Consistent with previous findings that Seipin has a cellautonomous function in the regulation of adipogenesis and adipocyte differentiation [13, 14] , our results reveal a tissueautonomous role of dSeipin in controlling lipid storage in adipocytes. Since the function of Seipin is conserved through evolution (this study and [18, 19] ), mammalian Seipin may have a similar role in lipid storage in mature adipocytes. Moreover, although the gross morphology of dSeipin mutant fat bodies appears normal, the lipid storage defects may reflect impaired fat body differentiation.
More importantly, our studies uncover an unexpected tissueautonomous role of Seipin in preventing ectopic lipid storage in non-adipose tissues. Ectopic lipid storage is one of the main causes of pathological conditions in obesity and lipodystrophy [4, 5] . Our in vivo studies demonstrated that defects within non-adipose tissues are the primary cause of ectopic lipid storage in dSeipin mutants. Is this tissue-autonomous mechanism specific to Seipin and lipodystrophy? Many mouse models of lipodystrophy and obesity associated with ectopic lipid storage in liver and muscles have been reported. High serum free fatty acid levels are thought to be the primary cause of liver steatosis in several studies, implicating tissue-non-autonomous regulatory effects in ectopic lipid storage [38, 39] . Interestingly, mice deficient in AGPAT2, the BSCL1 lipodystrophy gene, were recently found to have normal or low levels of serum free fatty acids, but still developed robust liver steatosis [40] . Instead of being caused primarily by high serum free fatty acid levels, hepatic steatosis in AGPAT2 mice could be explained by a tissue-autonomous function of AGPAT2. If this is true, both AGPAT2 and Seipin probably have tissue-autonomous functions in preventing ectopic lipid storage. Thus, the tissueautonomous mechanism of ectopic lipid storage could be a general theme in lipodystrophy. It will be interesting to examine whether the ectopic lipid storage in previously reported mouse models of obesity and lipodystrophy are caused by tissue-autonomous or tissue-non-autonomous mechanisms.
Within a cell, lipid storage could originate in two ways, increased lipogenesis and reduced lipolysis. We hypothesize that Seipin is involved in lipogenesis. The synergistic genetic interactions between dSeipin and lipogenic genes, in particular DGAT, strongly argue that Seipin participates in the lipogenic pathway. Ectopic lipid storage in salivary glands was observed in animals with overexpression of the lipogenic gene GPAT1, but not in loss-offunction mutants of the lipolytic gene bmm, suggesting that increased lipogenesis but not reduced lipolysis causes ectopic lipid storage in vivo. Thus, Seipin mutants may have increased lipogenic activity in non-adipose tissues, which subsequently results in the formation of ectopic lipid droplets in midgut and salivary glands as shown in Figure 3A and 3B.
Based on the lipidomic data and the genetic interactions between dSeipin and lipogenic genes, we propose that dSeipin participates in PA metabolism. Several lines of evidence support this hypothesis. Firstly, CdsA 1 mutants, which have increased levels of PA34:2, exhibit the same ectopic lipid droplet phenotype as dSeipin mutants ( Figure 6I ). Secondly, dSeipin synergizes with CdsA 1 , which is a partial loss-of-function mutant of CdsA, in ectopic lipid droplet formation ( Figure 6J ). Thirdly, overexpression of CdsA can fully suppress the ectopic lipid droplet phenotype of dSeipin mutants ( Figure 6L ). Fourthly, dSeipin also synergizes with CdsA in the formation of large lipid droplets in Drosophila S2 cells ( Figure  S4 ). Lastly, AGPAT2-deficient mice have increased levels of PA, which may lead to ectopic lipid storage in a tissue-autonomous fashion [40] . Therefore, it is likely that three known lipodystrophy genes (AGPAT2, Lipin and Seipin) are all involved in PA metabolism [11, 12, 41] . Although it has been suggested that hepatic TAG accumulation in AGPAT2-deficient mice is caused by a bypass pathway from LPA to monoacylglyceride (MAG) and subsequently to TAG, the contribution of elevated PA to excess TAG remains to be determined. Moreover, the exact cause of the increased levels of PA in AGPAT2-deficient mice is unclear. It could be due to elevated DAG kinase activity or increased expression of other AGPATs, such as AGPAT1, 3, and 8 [40] . The lipid profile of human Seipin mutant lymphoblastoid cell lines has been studied [42] . However, in that study the levels of PA weren't measured. Interestingly, it was found that the levels of unsaturated TAG species are decreased along with the increases of saturated TAG species. In our lipidomic analysis, the levels of unsaturated DAG and TAG species were significantly increased in salivary gland ( Figure 7 ). These results suggest that different cells/tissues may response differently to Seipin mutation.
Although the exact molecular function of dSeipin remains unclear, we propose that Seipin might act as an enzyme or a cofactor in regulating glycerolipid (likely PA) metabolism. PA occupies a specific branch point in the glycerolipid biosynthetic pathway. It can be converted to DAG by Lipin, or to CDP-DAG by CDS. DAG is the immediate precursor of TAG and PC, while CDP-DAG is the precursor of PI and PG. We propose that Seipin may influence lipogenesis by diverting PA from the lipogenic pathway in non-adipose tissues, such as the salivary gland. In the absence of Seipin the lipogenic pathway is more active, leading to lipid droplet formation. In addition, it is possible that PA could influence the formation of lipid droplets since the surface of lipid droplets is a monolayer of polar lipids.
dSeipin mutants display opposite phenotypes in the fat body and salivary gland, but we still do not know why there is reduced lipid storage in the fat body of dSeipin mutants. It is possible that compared to the salivary gland, the fat body responds differently to altered levels of phospholipids. Alternatively, Seipin might have different roles in different tissues. These two possibilities are not mutually exclusive, although the specific rescue of the lipid storage phenotype in the fat body but not the salivary gland by C-terminal truncation of dSeipin favors the latter possibility. Identification of the specific function and the binding partner of the C-terminal region in the near future will shed more light on the exact function of Seipin.
In summary, the Drosophila Seipin model has not only revealed a novel tissue-autonomous mechanism of ectopic lipid storage in lipodystrophy but has provided a new genetic tool to further identify the regulatory machinery controlling lipid storage. Additional studies combining yeast, Drosophila and mouse models will further advance our knowledge on lipodystrophy and benefit the development of therapeutic strategies to combat lipid storage diseases such as obesity.
Materials and Methods
Drosophila stocks and husbandry
Unless specified, Drosophila stocks were maintained in standard corn meal food with Angel dry yeast (Angel Yeast CO., LTD, Hubei, China). Canton-S was used as wild type and the transgenic line for generating dSeipin null mutants was treated as the control in some experiments where indicated. All stocks were obtained from the Bloomington Stock Center, the Harvard collection or the Vienna Drosophila RNAi center (for all RNAi stocks) except for pplGal4, bmm 1 , UAS-bmm, and CdsA
1
. All Gal4 lines were verified by crossing to UAS-GFP before use (Table S1 ). The effects of overexpression or RNAi of many lipogenic genes were also verified by qRT-PCR ( Figure S4 ). To generated dSeipin null mutants, we followed the ends-out procedure developed by Golic et al [43] with minor modifications [44] . A dSeipin knockout allele was isolated and confirmed by PCR. The mutant was backcrossed three times to w 1118 (control) to eliminate background mutations. Transgenic stocks were generated by standard methods.
Molecular biology
The coding region of Lsd-1 (without the stop codon) was amplified by RT-PCR and inserted into a T vector. The Lsd-1-mCherry fusion was created by ligating the Lsd-1 coding region (EcoRI-KpnI) in frame into a mCherry vector. The Lsd-1-mCherry fragment (EcoRI and XbaI) was shuttled to the transformation vector pUAST-attB to yield UAS-Lsd-1-mCherry. For UAS-dSeipin, full length cDNA was amplified from clone SD04409 and inserted into the pUAST-attB vector (EcoRI and XhoI). UASdSeipin-YFP was generated by replacing the stop codon of the cDNA with a BglII site. For UAS-hSeipin, hSeipin cDNA was amplified from human SY5Y cells and inserted into the BglII and XhoI sites of the pUAST vector. The S90L mutation of hSeipin was generated through site-directed mutagenesis. All constructs requiring PCR amplification were confirmed by sequencing. All qRT-PCRs were performed on an ABI PRISM 7900HT realtime cycler (Applied Biosystems) using Power SYBR Green PCR Master Mix (Applied Biosystems). Primer sequences are listed in Table S3 .
Staining and microscopy
For in situ hybridization, a 270bp dSeipin cDNA fragment was amplified and subcloned into pEasy-T3 vector with the following primers: 59-agatctATGCCGGCCATATCGCACAC-39and 59-aagcttGCGCATCATGGCAGACCGAC-39. An anti-sense digoxygenin-labeled probe was made using a BglII-linearized template. Hybridization was detected by using anti-DIG alkaline phosphatase and the CBIP/NBT substrate (Roche). For lipid droplet staining, larvae were dissected in PBS and fixed in 4% paraformaldehyde/PBS for 30 min at room temperature. Tissues were then rinsed twice with 16PBS, incubated for 30 min in either a 1:2500 dilution with PBS of 0.5mg/ml Nile red (Sigma), or 0.06% Oil Red O (Sigma), or a 1:1000 dilution with PBS of 1mg/ ml BODIPY 493/503 (Invitrogen), and then rinsed twice with distilled water. Stained samples were mounted in 80% glycerol. For lysotracker staining, fed or starved larvae were dissected in 1:1000 lysotracker (Invitrogen) and incubated for 5 min before mounting to a slide. All images were taken using a Nikon confocal scope or Zeiss fluorescent scope. The relative levels of lipid storage in fat body cells and salivary glands were quantified separately. Briefly, for lipid storage in fat body cells, the Nile red-positive areas of 30 fat body cells per genotype were measured by NIS-Elements BR 3.0 and then normalized to the whole cell area. The average lipid storage in wild type was set as 1. For lipid storage in salivary glands, the Nile red positive areas of 15 salivary glands per genotype were measured by NIS-Elements BR 3.0 and normalized to the whole cell area. The average lipid storage in dSeipin mutants was set as 1.
Cell culture and RNAi by dsRNA soaking Drosophila S2 cells were cultured in Schneider's Drosophila medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) at 25uC. dsRNA for RNAi treatment was produced by in vitro transcription of a PCR-generated DNA template containing the T7 sequence at both ends. The dsRNAs were generated using a MEGAscript T7 kit (Ambion). Two different sets of primers were used for targeted genes, and the one with better RNAi efficiency was used for the experiments reported. The primer sequences for dSeipin were: forward, 59-gaattaatacgactcactatagggagaCCATATCGCA-CACCCGAC-39, and reverse, 59-gaattaatacgactcactatagggagaAC-TATGGCCGACAATACG-39. The primer sequences for CdsA were: forward, 59-gaattaatacgactcactatagggagaTTTGGTTCGT-GCTCTCACTG-39, and reverse, 59-gaattaatacgactcactatagggagaCGTGAACAAATAGCTTGGCA-39. S2 cells were diluted to a final concentration of 5610 6 cells/ml in Schneider's Drosophila medium without FBS in 6-well plates. 20 mg dsRNA was added to 1 ml of cell suspension and incubated for 45 minutes at 25uC. After the incubation, 3 ml complete medium was added and the cells were cultured for another 3 days. Cells were collected and split into two for total RNA extraction and Bodipy staining.
Drosophila phenotypic analysis
For larvae starvation, wild type and mutant embryos were collected within a 4 hr period and raised at low density on standard fly food at 25uC. 60-65 hr after hatching, larvae were either fed with normal food or starved in PBS for 24 hr. Fed and starved larvae were then dissected and stained with Nile red or Oil Red O. Adult starvation tests were performed by transferring flies into vials (25 flies per vial) with filter papers soaked with distilled water. Mortality rates were determined by regularly counting the number of dead flies. For each genotype, triplicate batches of 75 male flies each (,36 hr of age) were used.
Glyceride analysis
To determine total glyceride, ten male flies were homogenized in 100 ml PBST (0.05% Tween 20), incubated at 70uC for 15 min and then centrifuged at 1,200 rpm for 5 min. The supernatants were incubated with Triglyceride analysis reagent (Biosino Biotechnology) at 37uC for 10 min before being analyzed with a Bio-RAD 550 microplate reader at 490 nm. Glyceride levels were normalized to protein levels using a Bradford assay. Hemolymph was collected from L3 larvae (20 from each group) and diluted in 50 ml PBST (0.05% Tween 20), heated at 70uC for 5 min, and centrifuged at 12,000 rpm for 5 min. Glyceride in the hemolymph supernatant was measured using TAG determination kits (Sigma).
Analysis of lipids using high performance liquid chromatography/mass spectrometry Lipids from salivary glands of 50 larvae, fat bodies of 50 larvae or 10 whole larvae (three sets of samples per genotype) were extracted as previously described [36] . An Agilent high performance liquid chromatography (HPLC) system coupled with an Applied Biosystem Triple Quadrupole/Ion Trap mass spectrometer (3200Qtrap) was used for quantification of individual phospholipids. Multiple reaction monitoring (MRM) transitions were set up for quantitative analysis of various polar lipids [19, 45] . Normal phase HPLC was set up for separation of individual lipid classes. Levels of individual lipids were quantified using spiked internal standards including dimyristoyl dimyristoyl phosphatidic acid (28:0-PA), which was obtained from Avanti Polar Lipids. Neutral lipids were analyzed using a sensitive HPLC/ESI/MRM method modified from a previous method [46] . TAG levels were calculated relative to the spiked d5-TAG 48:0 internal standard (CDN Isotopes Inc.), while DAGs were quantified using 4ME 16:0 Diether DG (Avanti) as an internal standard. The results from three experiments were normalized and plotted in a heat map. Figure S1 The Seipin homolog in Drosophila. (A) Sequence alignment of Seipin homolog proteins from yeast (FLD1p), worm (R01B10.6), fly (CG9904), mouse (Q9Z2E9.2) and human (NP116056). Human Seipin has two isoforms and only the short isoform (NP116056) was used for alignment. The two residues (N88 and S90) in hSeipin that are mutated in Silver syndrome are marked with asterisks. (B) The expression pattern of dSeipin mRNA is revealed by in situ hybridization. Black arrow: hindgut in the embryo; white arrow: nuclei of larval fat body; arrowhead: larval anterior midgut. dSeipin mutants were used as negative controls. (C) Colocalization of dSeipin-YFP with the ER marker PDI-GFP. To detect YFP signal and minimize GFP fluorescent leak-through, the emission detector in the confocal microscope was set up to allow only strong YFP signal to pass. 
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